Literature DB >> 22688754

The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review.

Thomas C Hall1, Ashley R Dennison, Giuseppe Garcea.   

Abstract

OBJECTIVES: Sphincter of Oddi dysfunction (SOD) is a benign pathological syndrome. The clinical manifestations may be a consequence of an anatomical stenosis or sphincter dysmotility. Manometry is invasive and has an associated morbidity. Non-invasive investigations have been evaluated to ameliorate risk but have unknown efficacy. The review aims to critically appraise current evidence for the diagnosis and management of SOD.
METHODS: A systematic review of articles containing relevant search terms was performed.
RESULTS: Manometry is the current gold standard in selecting which patients are likely to benefit from endoscopic sphincterotomy (ES). It can, however, be misleading. Several non-invasive investigations were identified. These have poor sensitivities and specificities compared to manometry. There is a paucity of data examining the investigation's specific ability to select patients for ES. Outcomes of ES for Type I SOD are favourable irrespective of manometry. Types II and III SOD may respond to an initial trial of medical therapy. Manometry may predict response to ES in Type II SOD, but not in Type III.
CONCLUSIONS: Non-invasive investigations currently lack sufficient sensitivities and specificities for routine use in diagnosing SOD. Type I SOD should be treated with ES without manometry. Manometry may be useful for Type II SOD. However, whilst data is lacking a therapeutic trial of Botox(TM) or trial stenting may bean alternative. Careful and thorough patient counselling is essential. Type III SOD is associated with high complications from manometry and poor outcomes from ES. Alternative diagnoses should be thoroughly sought and its management should be medical.

Entities:  

Mesh:

Year:  2012        PMID: 22688754     DOI: 10.1007/s00423-012-0971-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  56 in total

Review 1.  Sphincter of Oddi dysfunction: overdue for an overhaul.

Authors:  John Baillie
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

2.  Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction.

Authors:  Martin L Freeman; Muzaffar Gill; Carol Overby; Ye-Ying Cen
Journal:  J Clin Gastroenterol       Date:  2007-01       Impact factor: 3.062

3.  Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction.

Authors:  M L Rosenblatt; M F Catalano; E Alcocer; J E Geenen
Journal:  Gastrointest Endosc       Date:  2001-12       Impact factor: 9.427

4.  Cholecystokinin-Stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility.

Authors:  B C Pineau; W L Knapple; K M Spicer; L Gordon; M Wallace; W S Hennessy; R H Hawes; P B Cotton
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy.

Authors:  M Cicala; F I Habib; P Vavassori; N Pallotta; O Schillaci; G Costamagna; M P L Guarino; F Scopinaro; F Fiocca; A Torsoli; E Corazziari
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Risk factors for post-ERCP pancreatitis: a prospective multicenter study.

Authors:  Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

7.  Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.

Authors:  E L Fogel; D Eversman; P Jamidar; S Sherman; G A Lehman
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

8.  Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.

Authors:  M S Khuroo; S A Zargar; G N Yattoo
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

9.  Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry.

Authors:  Evangelos Kalaitzakis; Tim Ambrose; Jane Phillips-Hughes; Jane Collier; Roger W Chapman
Journal:  BMC Gastroenterol       Date:  2010-10-22       Impact factor: 3.067

10.  MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.

Authors:  Pier Alberto Testoni; Alberto Mariani; Simona Curioni; Alessandro Zanello; Enzo Masci
Journal:  Gastrointest Endosc       Date:  2008-01-07       Impact factor: 9.427

View more
  7 in total

1.  Secretin-Enhanced MRCP: How and Why-AJR Expert Panel Narrative Review.

Authors:  Jordan Swensson; Atif Zaheer; Darwin Conwell; Kumar Sandrasegaran; Riccardo Manfredi; Temel Tirkes
Journal:  AJR Am J Roentgenol       Date:  2021-03-11       Impact factor: 3.959

2.  Cystic form of paraduodenal pancreatitis (cystic dystrophy in heterotopic pancreas (CDHP)): a potential link with minor papilla abnormalities? A study in a large series.

Authors:  M Wagner; M P Vullierme; V Rebours; M Ronot; P Ruszniewski; V Vilgrain
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

3.  Laparoscopic hepaticoplasty using gallbladder as a subcutaneous tunnel for hepatolithiasis.

Authors:  Long Cui; Zhi Xu; Xiao-Feng Ling; Li-Xin Wang; Chun-Sheng Hou; Gang Wang; Xiao-Si Zhou
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

4.  Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass.

Authors:  Chin Hong Lim; Cyrus Jahansouz; Martin L Freeman; Daniel B Leslie; Sayeed Ikramuddin; Stuart K Amateau
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

Review 5.  Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment.

Authors:  Pier Alberto Testoni
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Opium-related sphincter of Oddi dysfunction causing double duct sign.

Authors:  Vishal Sharma; Surinder Singh Rana; Vinita Chaudhary; Narendra Dhaka; Manish Manrai; Jegan Sivalingam; Ravi Sharma; Usha Dutta; Deepak Kumar Bhasin
Journal:  Endosc Ultrasound       Date:  2016 Jul-Aug       Impact factor: 5.628

7.  Surgical ampullectomy: an underestimated operation in the era of endoscopy.

Authors:  Lutz Schneider; Pietro Contin; Stefan Fritz; Oliver Strobel; Markus W Büchler; Thilo Hackert
Journal:  HPB (Oxford)       Date:  2015-12-08       Impact factor: 3.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.